🔎 Trials Near Me

Utama › Penyakit Usus Radang › Illinois

Kajian klinikal Penyakit Usus Radang di Illinois

7 kajian untuk Penyakit Usus Radang sedang mencari peserta di lokasi di Illinois.

Bandar di Illinois

Teks kajian rasmi (Bahasa Inggeris)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Northwestern University, Chicago
  • Avicenna Clinical Research - SW Gastroenterology, Oak Lawn
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 038, Chicago
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-005, Des Plaines
  • Site US-007, Glenview
  • Site US-020, Gurnee
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07845487

A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication

  • Northwest Gastroenterologist, Glenview
Mengambil pesertaFasa 4
3 Weeks · Wanita · Dikemas kini 8 Sep 2026 · NCT07612267

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

  • Rush University Medical Center, Chicago
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jun 2026 · NCT05579392

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Glenview
  • Mirador Therapeutics Selected Site, Gurnee
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

  • University of Chicago Medical Center, Chicago
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mac 2026 · NCT01280825

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.